Drug Profile
JIN 2017
Alternative Names: JIN2017Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Jina Pharmaceuticals
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Cancer in Unknown (IV)
- 18 May 2012 Clinical trials in Cancer (IV)